Definium Therapeutics (DFTX) Debt Ratio (2023 - 2026)

Definium Therapeutics (DFTX) has reported Debt Ratio for 4 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio rose 26.95% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (up 26.95% YoY), while the FY2025 annual figure was 0.09, up 27.48% from the prior year.
• Debt Ratio rose to 0.1 in Q1 2026 per DFTX's latest filing, from 0.09 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.17 in Q3 2025 and bottomed at 0.05 in Q1 2024.
• Historically, Debt Ratio has averaged 0.1 across 4 years, with a median of 0.09 in 2025.
• Annual changes were most pronounced in 2024 — Debt Ratio slumped 36.25% — and 2025, when it jumped 124.21%.
• Definium Therapeutics' Debt Ratio stood at 0.11 in 2023, then slumped by 36.25% to 0.07 in 2024, then increased by 27.48% to 0.09 in 2025, then increased by 10.19% to 0.1 in 2026.
• Business Quant data shows DFTX's Debt Ratio at 0.1 in Q1 2026, 0.09 in Q4 2025, and 0.17 in Q3 2025.